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INTRODUCTION
The metabolic syndrome, also called ‘‘syndrome X’’, ‘‘insulin
resistance syndrome’’, or ‘‘cardiometabolic syndrome’’, refers
to the state in which metabolic risk factors for cardiovascular
diseases are clustered in individuals. The factors include abdo-
minal obesity, atherogenic dyslipidemia, raised blood pressure
(BP), insulin resistance, prothrombotic state, and proinflam-
matory state (1).
Since the work of Reaven (2), the evidences that the meta-
bolic syndrome increases the risk for morbidity and mortality
of cardiovascular disease have accumulated (3-5). Studies have
shown that metabolic factors tend to aggregate in individuals,
and that clustering is more harmful than having an individ-
ual single factor.
Unfortunately, prevalence of insulin resistance or type 2
diabetes has increased on a worldwide level, especially in non-
Europe, Asian regions. This phenomenon has been called
‘‘diabetes epidemic’’ (6). However, nationwide prevalence of
the syndrome or its relationship with cardiovascular diseases
has not yet been reported in Korea. Previous studies involved
subjects who were either the residents of specific localities
(7, 8) or voluntary clients of a university hospital (9-13), and
therefore the estimates could not be generalized. Moreover,
different case definitions used in these studies set limits to
comparison.
This study was undertaken to estimate the nationwide pre-
valence of the metabolic syndrome and its individual compo-
nents among Korean adults, and to explore its relationship
with cardiovascular diseases.
MATERIALS AND METHODS
Data collection
In 1998, the first Korea National Health and Nutrition
Survey was conducted. It involved a health interview survey,
health behavior survey, and dietary survey by home visits and
health examination survey at local centers. Anthropometric
measurement including height, weight, waist circumference
(WC), and hip girth was performed. Systolic and diastolic BP
were measured twice using a sphygmomanometer at phase I
and V, respectively, and were averaged. The subjects went
through more than 10 hr fasting and blood samples were
obtained using venupucture. The blood samples were analyzed
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Prevalence of the Metabolic Syndrome and Its Association with
Cardiovascular Diseases in Korea
This study aimed to estimate nationwide prevalence of the metabolic syndrome and
to identify its association with cardiovascular diseases. The data on a national rep-
resentative sample of 6,147 adults from 1998 Korea National Health and Nutrition
Survey were analyzed. The syndrome was determined according to two kinds of
modified definition from ATP III, in which abdominal obesity was determined by waist
circumference (WC) standard for Asians and waist-to-hip ratio (WHR). Based on the
former, prevalence was 22.1% in men and 27.8% in women. However, based on
the latter, prevalence was 28.6% and 27.8%, respectively. Although age-specific
prevalence was higher in men than in women among the younger group, it became
higher in women among the older group because of its steeper rise with age. In mul-
tiple logistic regression, the syndrome was found to be positively associated with
cardiovascular diseases (adjusted odds ratios (ORs)1.97 by WC and 1.48 by WHR
in men, and 1.54 and 1.31 in women). Moreover, its effect size exceeded that of
total cholesterol (adjusted ORs 1.21 in men, and 1.08 in women) or LDL cholesterol
(1.58 in men and 1.22 in women). It is obvious that the metabolic syndrome prevails
in Korea, and its importance regarding cardiovascular diseases is considerable. Pre-
vention strategies should be implemented immediately to avoid cardiovascular epi-
demic in the near future.
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for serum total cholesterol (TC), triglycerides (TG), high-den-
sity lipoprotein cholesterol (HDL), and fasting blood glucose
(FBS) (Hitachi-747 autoanalyzer; Hitachi, Japan). In addition,
current medication status for hypertension or diabetes, personal
history of cardiovascular disease including cerebrovascular
disease and ischemic heart disease, and family history of dia-
betes, cerebrovascular disease, or ischemic heart disease were
determined by self-reports.
The subjects were selected based on stratified multistage
probability sampling, and generalization to the general pop-
ulation of Korea is possible. We analyzed the data of 2,731
men and 3,416 women aged 25 yr and over who completed
all the items of health examination. In order to estimate nation-
wide prevalence we applied sample weights proposed by Korea
Institute of Health and Social Affairs (14).
Case definition
The metabolic syndrome was defined according to 2001
National Cholesterol Education Program Adult Treatment
Panel III (ATP III) (1), except for abdominal obesity by WC
which did not seem applicable to relatively lean Asian people.
WC is known to directly reflect abdominal fat mass and to
have a good correlation with other metabolic components
(15), and Inoue et al. proposed WC standard for Asians (16).
However, Bjorntorp reported that actual cardiovascular risk
is more correlated with waist-to-hip ratio (WHR) than WC
because the former includes hip girth reflecting muscle mass
important in insulin regulation as well as WC reflecting
abdominal fat (17). The World Health Organization (WHO)
proposed the WHR standard to determine the metabolic
syndrome in 1998 (18). Hence, in this study, we used both
WHR and WC to fix two kinds of definitions for the meta-
bolic syndrome, and compared the results (19). The syndrome
was defined as having 3 or more components from the fol-
lowing: 1) abdominal obesity (a) WC ≥90 cm in men and
80 cm in women (16), or (b) WHR >0.9 in men, and 0.85
in women (18); 2) high TG ≥150 mg/dL; 3) low HDL <40
mg/dL in men, and <50 mg/dL in women; 4) high BP ≥
130/85 mmHg or current medication; and 5) high FBS ≥
110 mg/dL or current medication (1).
Other metabolic abnormalities were defined as: 1) high TC
≥240 mg/dL; and 2) high low-density lipoprotein cholesterol
(LDL) ≥160 mg/dL (1). 
Cardiovascular cases were determined based on self-reports,
in which the participants stated that they were affected by
cerebrovascular diseases, ischemic heart disease, or other heart
diseases.
Statistical analysis
The prevalence of the metabolic syndrome and its individual
components was calculated using sample weights to obtain
the nationwide representative estimates.
Theoretically, prospective studies are necessary in order to
identify the causal association between the syndrome and car-
diovascular diseases, but this could not be done in this study.
Therefore, the cross-sectional associations between them were
examined (19). Age-adjusted odds ratios (ORs) of metabolic
abnormalities for cardiovascular disease and covariates-adjust-
ed ORs were estimated using logistic regression models. The
covariates were chosen through stepwise selection among age,
family history of hypertension, diabetes, or ischemic heart
disease (yes or no), depression (never, often, or always), smoking
(never, ex, or current smoker), drinking (never, ex, or current
drinker), weight change (constant, increase, or decrease), regu-
lar exercise (vigorous, moderate, or never), lifestyle (active,
modest, or sedentary), and carbohydrate intakes (<60, 60-70,
or >70% of total energy intake). All analyses were performed
separately according to gender using SAS version 8.1.
RESULTS
Table 1 shows the anthropometric and metabolic character-
istics of the participants. The average levels of WC, WHR,
Variables
Korean
Men Women Men Women
American 
(White)*
Number of subjects 2,731 3,416 1,398 1,611
Age (yr) 44.6 (±16.36) 46.5 (±17.49)
Height (cm) 168.7 (±7.50) 155.7 (±7.08) 175.4 161.2
Weight (kg) 66.2 (±11.64) 56.7 (±9.82) 82.1 68.3
Waist circumf- 83.2 (±9.73) 78.8 (±10.67) 97.9 89.6
erence (cm)
Hip girth (cm) 93.9 (±7.46) 93.8 (±7.67) - -
Waist to hip ratio 0.89 (±0.074) 0.84 (±0.086) 0.98 0.88
Body mass index  23.2 (±3.48) 23.4 (±3.73) 26.6 26.3
(kg/m
2)
Systolic BP (mmHg) 127.7 (±21.89) 124.4 (±23.93) 126.7 121.6
Diastolic BP (mmHg) 81.4 (±14.34) 76.4 (±13.28) 74.8 69.6
Total cholesterol  188.2 (±43.06) 189.2 (±41.91) 207.7 213.9
(mg/dL)
HDL cholesterol 47.7 (±14.22) 51.2 (±13.79) 44.9 54.8
(mg/dL)
Triglyceride 136.4  (±75.54) 111.6 (±59.94) 151.5 139.8
(mg/dL)
LDL cholesterol  113.2 (±39.34) 115.7 (±37.31) 133.5 130.7
(mg/dL)
�
Fasting blood 102.2 (±36.17) 100.9 (±36.55) 101.7 100.4
glucose (mg/dL)
Table 1. Anthropometric and metabolic characteristics among
Korean adults aged ≥25 yr, from Korea National Health and
Nutrition Survey in 1998
*The estimates were quoted from the article of Okosun and collegues,
which analyzed the sample of NHANES III in the United States (15). 
� It
was calculated by Friedwald Equations in our study, while directly mea-
sured in Americans.
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systolic and diastolic BP, and TG were much higher in men
than in women, and those of hip girth, body mass index (BMI),
and TC did not significantly differ between gender. However,
HDL and LDL levels were higher in women. Because these
samples were representative, the estimates indicated the cur-
rent level of national averages, and even after age-standardiza-
tion, the gender differences remained alike except for LDL and
FBS. Though crude comparison with American whites (obtain-
ed from NHANES III, 1988-1994) (15) without considering
demographic structure is questionable, the BMI of Korean
men and women was lower than that of American whites on
the average: 23.2 vs. 26.6 kg/m2 in men, and 23.4 vs. 26.3
kg/m2 in women. As for abdominal obesity, WC of Korean
men and women (83.2 and 78.8 cm) was smaller by 12-16
cm than that of American men and women (97.9 and 89.6
cm, respectively). In addition, Americans showed more adverse
lipid profiles, such as higher TC, TG, and LDL. However, BP
level was higher in Koreans, and FBS level did not seem to
differ much between them (Table 1).
Table 2 shows the distribution of overlapping abnormalities.
The proportion of subjects having at least one component was
over 75%. As the number of abnormalities increased, preva-
lence decreased. Among men, prevalence of abdominal obesity
by WHR standard was higher than that by WC, but there
was no difference in women. Prevalence of the metabolic syn-
drome, defined as having 3 or more components, was 22.1%
(by WC) and 28.6% (by WHR) in men, and 27.8% (by WC
as well as WHR) in women (Table 2).
Table 3 presents the prevalence of the metabolic abnormali-
ties. Prevalence of abdominal obesity based on WC and WHR
differed considerably in men but not in women. If the WC
standard was used, prevalence of women was nearly twice that
of men, but if WHR was used the prevalence did not differ
much (p=0.460). Those of low HDL (49.0%), high TC (9.8%),
and high LDL (9.7%) were higher in women, while high BP
(47.2%), high TG (37.3%), and high FBS (22.1%) were more
prevalent in men (all p<.01). Even after age-standardization,
the pattern remained alike (Table 3). Among the cases of meta-
bolic syndrome, high TG and high BP were remarkably preva-
lent (over 75%) in men, while low HDL, abdominal obesity,
and high BP were in women (data not shown).
To explore prevalence differentials caused by abdominal
obesity standards, the relationship among WC, hip girth, and
*Metabolic abnormalities were defined ATP III, criteria for abdominal
obesity was replaced with waist circumference (WC) for Asians, and
waist to hip ratio (WHR). 
� It indicates the metabolic syndrome.
units: % (±standard error).
Number 
of abnor-
malities
Men
ATP III+WC* ATP III+WHR*
Women
ATP III+WC* ATP III+WHR*
≥1 76.4 (±0.81) 80.2 (±0.76) 75.8 (±0.73) 76.0 (±0.73)
≥2 46.4 (±0.85) 53.1 (±0.95) 49.3 (±0.86) 49.0 (±0.86)
≥3
� 22.1 (±0.79) 28.6 (±0.86) 27.8 (±0.77) 27.8 (±0.77)
≥4 7.3 (±0.50) 10.4 (±0.58) 11.9 (±0.55) 12.1 (±0.56)
5 1.3 (±0.22) 1.8 (±0.26) 3.2 (±0.30) 3.1 (±0.30)
Table 2. Prevalence of overlapping abnormalities of the metabolic
syndrome among Korean adults aged ≥25 yr, from Korea Nation-
al Health and Nutrition Survey in 1998
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Fig. 1. Relationships among waist circumference (WC), hip girth, and waist to hip ratio (WHR) by age group.
A B
*Case definition: 1) abdominal obesity (WC) ≥90 cm in men and 80 cm
in women; 2) abdominal obesity (WHR) >0.9 in men, and 0.85 in women;
3) high BP ≥130/85 mmHg or current medication; 4) low HDL <40
mg/dL in men, and <50 mg/dL in women; 5) high TG ≥150 mg/dL; 6)
high FBS ≥110 mg/dL or current medication; 7) high TC ≥240 mg/dL;
and 8) high LDL ≥160 mg/dL. 
� by 
2 test.
units: % (±standard error).
Metabolic abnormality*
Men
(n=2,731)
Women
(n=3,416)
p-value
�
Abdominal obesity (WC) 21.0 (±0.78) 42.4 (±0.85) <.0001
Abdominal obesity (WHR) 41.6 (±0.94) 42.5 (±0.85) 0.4597
High BP 47.2 (±0.96) 35.5 (±0.82) <.0001
Low HDL 26.0 (±0.84) 49.0 (±0.86) <.0001
High TG 37.3 (±0.93) 22.1 (±0.71) <.0001
High FBS 22.1 (±0.79) 19.0 (±0.67) 0.0005
High TC 7.9 (±0.52) 9.8 (±0.51) 0.0035
High LDL 7.9 (±0.52) 9.7 (±0.50) 0.0048
Table 3. Prevalence of individual metabolic abnormalities among
Korean adults aged ≥25 yr, from Korea National Health and
Nutrition Survey in 1998198 M.-H. Kim, M.-K. Kim, B.-Y. Choi, et al.
WHR were examined according to age group and gender.
As shown in Fig. 1, in men, both WC and hip girth decreased
slowly with age, but the slope in hip girth was more steeper,
resulting in the rise of WHR with age. On the contrary, in
women, while hip girth seemed constant across age groups,
WC rise was remarkable, also giving WHR increase with
age (Fig. 1).
Fig. 2 shows the age-specific prevalence of the metabolic
syndrome and its individual abnormalities. Prevalence of
abdominal obesity by WHR, high BP, high TG, and high
FBS was higher in men than in women among the age groups
under 55 yr. However, its rise according to age was steeper
in women. Therefore, among the groups over 55 yr, prevalence
was much higher in women. Low HDL and abdominal obe-
sity based on WC was more prevalent in women across all age
groups. Age-specific prevalence of the metabolic syndrome
in men increased to 54 yr old, followed by decrease or plateau.
On the contrary, women had lower prevalence in the begin-
ning, but the increase according to age continued on after 55
yr old (Fig. 2). 
The relationship between the metabolic abnormalities and
cardiovascular diseases is shown in Table 4. Covariates-adjust-
Fig. 2. Age-specific prevalence of individual metabolic abnormalities of the metabolic syndrome among Korean adults aged ≥25 yr, from
Korea National Health & Nutrition Survey in 1998. *Metabolic syndrome was defined by ATP III, of which criteria for abdominal obesity was
replaced with waist circumference for Asians (WC), and waist to hip ratio (WHR).
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Bed ORs of the syndrome were 1.97 (95% CI 1.26-3.09, by
WC) and 1.48 (0.96-2.28, by WHR) in men, and 1.54 (1.15-
2.07, by WC) and 1.31 (0.97-1.75, by WHR) in women. The
impact of adjustment for covariates was not large. The covari-
ates-adjusted ORs of the syndrome by WC was larger than
that by WHR in both genders, and also larger than those of
individual abnormalities (Table 4).
DISCUSSION
This study analyzed a national representative sample obtain-
ed from the first nationwide health examination survey in
Korea 1998. External validity is therefore sufficient to inter-
pret the findings for the general population of Korea. 
As shown in Table 1, attributes of body physique and meta-
bolic factors were very different from American whites, there-
fore the case definition based on ATP III had to be modified.
Since there was no universal agreement, two different standards
were used for abdominal obesity (16, 18, 19), by which the
prevalence difference was large in men but was almost neg-
ligible in women (Table 2, 3). This phenomenon seemed to
result from the relationship among WC, hip girth, and WHR.
In women, WHR increase was pulled by WC rise, while in
men it was caused by disproportional decreases of hip girth
to WC (Fig. 1). 
According to Table 2 and 3, metabolic abnormalities are
very prevalent among Koreans, and roughly up to 8 million
adults are supposed to be affected by the metabolic syndrome.
The estimated prevalence of this study was higher than pre-
viously reported in Korea, being 9.8-20.8% in men and 10.3-
19.6% in women (7-13). Such difference partly resulted from
different case definition; for instance, two studies (7, 8) were
conducted before ATP III recommendation, and one study
(9) used ATP III with BMI standard instead of abdominal
obesity. However, more important reason of different results
lies in selection bias; although three studies (10, 11, 13) used
the same criteria as we applied, which means ATP III with
abdominal obesity standard for Asians, the estimated preva-
lences were much lower than ours. The subjects of those stud-
ies were recruited among the clients of comprehensive med-
ical examination in a university hospital, which implied that
they were likely to be younger and healthier, or having higher
social status so they could not represent general population
in Korea. In that socioeconomic factors are related to the meta-
bolic syndrome (20), the previously reported prevalences seem
to be underestimated.
In addition, estimate in the present study was higher than
that of American whites, which was 24.8% in men and 22.8%
in women (21). Such difference partly resulted from the dif-
ference in the case definition used (i.e., abdominal obesity) or
demographic structure. However, some studies showed that
Asians are more vulnerable to the metabolic risk compared
to Caucasians. Various studies comparing Asian ethnics, such
as Filipinos (22), Japanese (23, 24), and South Asians (25) with
Caucasians reported that Asians had higher risk of diabetes
or metabolic syndrome although they were less obese. This
study also supports such findings.
Even though the prevalence of the syndrome in men and
women was approximate, age-specific prevalence of the syn-
drome and its individual abnormalities significantly differed
(Fig. 2). In men, a plateau or decrease was observed in the age
groups over 55 yr, which was supposed to reflect cohort effect
or selective survival. On the contrary, in women, prevalence
continuously increased with age, which could in part be an
effect of menopause. Although menopausal status was not
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Group Risk factor*
Men
ORs (age-adjusted) Adjusted ORs
�
Women
ORs (age-adjusted) Adjusted ORs
�
Individual  High WC 1.68 (1.08-2.61) 1.55 (0.97-2.49) 1.24 (0.94-1.65) 1.37 (1.02-1.85)
metabolic  High WHR 1.60 (1.06-2.42) 1.54 (0.99-2.38) 0.88 (0.66-1.17) 0.93 (0.69-1.26)
risk factors High BP 1.58 (1.03-2.41) 1.57 (1.00-2.46) 1.24 (0.91-1.67) 1.25 (0.91-1.71)
Low HDL 2.23 (1.49-3.34) 1.93 (1.25-2.99) 0.98 (0.75-1.28) 0.98 (0.74-1.30)
High TG 1.14 (0.76-1.72) 1.31 (0.84-2.05) 1.32 (0.99-1.76) 1.36 (1.01-1.83)
High FBS 1.04 (0.67-1.61) 1.07 (0.67-1.70) 1.29 (0.96-1.73) 1.12 (0.82-1.53)
High TC 1.16 (0.58-2.31) 1.21 (0.58-2.51) 1.07 (0.74-1.54) 1.08 (0.73-1.58)
High LDL 1.67 (0.91-3.05) 1.58 (0.82-3.07) 1.27 (0.89-1.80) 1.22 (0.84-1.77)
Metabolic ATP  III+WC
� 1.89 (1.24-2.86) 1.97 (1.26-3.09) 1.53 (1.15-2.03) 1.54 (1.15-2.07)
syndrome ATP IIII+WHR
� 1.38 (0.93-2.07) 1.48 (0.96-2.28) 1.33 (1.00-1.76) 1.31 (0.97-1.75)
Table 4. Relationships between the metabolic abnormalities and cardiovascular diseases: odds ratios (ORs) from logistic regression  
*Case definition: 1) abdominal obesity (WC) ≥90 cm in men and 80 cm in women; 2) abdominal obesity (WHR) >0.9 in men, and 0.85 in women; 3)
high BP ≥130/85 mmHg or current medication; 4) low HDL <40 mg/dL in men, and <50 mg/dL in women; 5) high TG ≥150 mg/dL; 6) high FBS ≥
110 mg/dL or current medication; 7) high TC ≥240 mg/dL; and 8) high LDL ≥160 mg/dL. 
� Metabolic syndrome was defined by ATP III, of which cri-
teria for abdominal obesity was replaced with waist circumference for Asians (WC), and  waist to hip ratio (WHR). 
� Model includes (1) age, age
2, depres-
sion (never, often, or always), family history of hypertension, and family history of ischemic heart disease in men, (2) age, age
2, depression (never,
often, or always), family history of hypertension, and life style(sedentary, modest, or active) in women.
units: odds ratio (95% confidence interval).included in the survey, there was another study that reported
visceral fat accumulation and acute increase of insulin resistance
after menopause (23). 
For the association with cardiovascular diseases, the metabol-
ic syndrome was found to be positively related. The effect size
of the metabolic syndrome by WC standard was larger than
that by WHR, and the former seemed to have more closer
relationship. When using WC standard, the covariates-adjust-
ed OR of the syndrome in both gender was larger than indi-
vidual abnormalities, which agreed with the previous findings
that clustering of metabolic factors is more harmful than hav-
ing an individual single factor (3-5). However, because the
analysis was cross-sectional and the case definition of cardio-
vascular diseases was based on self-reports, no clear decision
could be made.
Whatever, in relation to population impact determined
by prevalence and effect size, control and prevention of the
metabolic syndrome is important for prevention of cardiovas-
cular disease in Korea. Although higher risk of women observ-
ed in other studies (3, 4) was not identified in this study, it
is still important to focus on women because prevalence of
the syndrome was considerably high in elderly women. 
In conclusion, this study shows that, no matter what stan-
dard for abdominal obesity was used, representative prevalence
of the metabolic syndrome among Korean adults was higher
than previous reported, and moreover, also higher than that
of American whites who are more obese than Koreans. Accord-
ing to the results, current cases might be up to 8 millions in
Korea, and they are supposed to have more risk for cardiovas-
cular diseases. We would like to recommend that usual health
examination include assessment of the metabolic syndrome,
and based on that, secondary prevention be implemented
immediately, especially among elderly women. Further studies
are necessary to define the level of metabolic abnormalities to
predict cardiovascular risk among relatively lean Asians and to
unravel determinants of the syndrome for primary prevention.
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